- 全部删除
您的购物车当前为空
SARS-CoV-2-IN-13 (compound 6) 是氯硝柳胺的类似物。在人血浆和肝S9酶测定中,SARS-CoV-2-IN-13 比氯硝柳胺更稳定。SARS-CoV-2-IN-13 口服给药时可以提高生物利用度和半衰期。SARS-CoV-2-IN-13 是SARS-CoV-2的有效抑制剂,IC50值为 0.057 μM。


为众多的药物研发团队赋能,
让新药发现更简单!
SARS-CoV-2-IN-13 (compound 6) 是氯硝柳胺的类似物。在人血浆和肝S9酶测定中,SARS-CoV-2-IN-13 比氯硝柳胺更稳定。SARS-CoV-2-IN-13 口服给药时可以提高生物利用度和半衰期。SARS-CoV-2-IN-13 是SARS-CoV-2的有效抑制剂,IC50值为 0.057 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 297 | In stock | |
| 5 mg | ¥ 738 | In stock | |
| 10 mg | ¥ 1,190 | In stock | |
| 25 mg | ¥ 2,390 | In stock | |
| 50 mg | ¥ 3,400 | In stock | |
| 100 mg | ¥ 4,750 | In stock | |
| 200 mg | ¥ 6,390 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 549 | In stock |
SARS-CoV-2-IN-13 相关产品
| 产品描述 | SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 μM [1]. |
| 分子量 | 327.12 |
| 分子式 | C13H8Cl2N2O4 |
| CAS No. | 56961-10-5 |
| Smiles | Oc1ccc(Cl)cc1C(=O)Nc1ccc(c(Cl)c1)[N+]([O-])=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 112.5 mg/mL (343.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容